Histone Demethylase Jumonji D3 (Jmjd3) As A Tumor Suppressor By Regulating P53 Protein Nuclear Stabilization

Chibawanye I Ene,Lincoln Edwards,Gregory Riddick,Mehmet Baysan,Kevin Woolard,Svetlana Kotliarova,Chen Lai,Galina Belova,Maggie Cam,Jennifer Walling,Ming Zhou,Holly Stevenson,Hong Sug Kim,Keith Killian,Timothy Veenstra,Rolanda Bailey,Hua Song,Wei Zhang,Howard A Fine,CI Ene

DOI: https://doi.org/10.1371/journal.pone.0051407

IF: 3.7

2012-01-01

PLoS ONE

Abstract:Histone methylation regulates normal stem cell fate decisions through a coordinated interplay between histone methyltransferases and demethylases at lineage specific genes. Malignant transformation is associated with aberrant accumulation of repressive histone modifications, such as polycomb mediated histone 3 lysine 27 (H3K27me3) resulting in a histone methylation mediated block to differentiation. The relevance, however, of histone demethylases in cancer remains less clear. We report that JMJD3, a H3K27me3 demethylase, is induced during differentiation of glioblastoma stem cells (GSCs), where it promotes a differentiation-like phenotype via chromatin dependent (INK4A/ARF locus activation) and chromatin independent (nuclear p53 protein stabilization) mechanisms. Our findings indicate that deregulation of JMJD3 may contribute to gliomagenesis via inhibition of the p53 pathway resulting in a block to terminal differentiation.